Critical Contrast: Edap Tms (NASDAQ:EDAP) versus Heart Tronics (OTCMKTS:HRTT)

Heart Tronics (OTCMKTS:HRTTGet Free Report) and Edap Tms (NASDAQ:EDAPGet Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Earnings & Valuation

This table compares Heart Tronics and Edap Tms’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Heart Tronics N/A N/A N/A N/A N/A
Edap Tms $65.42 million 3.11 -$22.92 million ($0.54) -10.17

Heart Tronics has higher earnings, but lower revenue than Edap Tms.


This table compares Heart Tronics and Edap Tms’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Heart Tronics N/A N/A N/A
Edap Tms -30.12% -31.44% -19.86%

Volatility and Risk

Heart Tronics has a beta of 713.97, meaning that its stock price is 71,297% more volatile than the S&P 500. Comparatively, Edap Tms has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.

Insider & Institutional Ownership

62.7% of Edap Tms shares are held by institutional investors. 0.2% of Edap Tms shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings for Heart Tronics and Edap Tms, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heart Tronics 0 0 0 0 N/A
Edap Tms 0 0 2 0 3.00

Edap Tms has a consensus price target of $14.00, suggesting a potential upside of 155.01%. Given Edap Tms’ higher probable upside, analysts clearly believe Edap Tms is more favorable than Heart Tronics.


Edap Tms beats Heart Tronics on 5 of the 9 factors compared between the two stocks.

About Heart Tronics

(Get Free Report)

Heart Tronics, Inc., a medical device company, engages in the research, development, and marketing of medical devices in the United States. Its medical devices are used to monitor and measure physiological signals in order to detect diseases that impact an individual's health. The company offers Fidelity 100 Monitor System, an integrated system in which its component Model 100 Patient Module collects, processes, and amplifies electrocardiogram (ECG) signals from that patient through a set of 10 electrodes that are wirelessly transmitted to the laptop computer. Its products in the development stage include Fidelity 350 Holter Monitor, an ambulatory Holter monitor that collects ECG data of arrhythmia and transient heart disease, while the patient carries out daily activities away from the physician's office or hospital. The company's products in the development stage also consist of Fidelity 200 Event Recording System/Heart Tempo Card, a non-prescription heart monitoring device, which is used as an early-detection device by patients who desire to monitor their condition. Its products also include Cardiac Vest, a lightweight, close-fitting vest or undergarment made of stretchable material in which the electrodes are stitched into the fabric; and Fidelity 400 Intracardiac Monitor that applies its proprietary physiological signal acquisition and amplification technology to read intracardiac signals procured from intracardiac catheter. The company was formerly known as Signalife, Inc. and changed its name to Heart Tronics, Inc. in November 2008. Heart Tronics, Inc. was incorporated in 1987 is headquartered in Studio City, California.

About Edap Tms

(Get Free Report)

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is based in Lyon, France.

Receive News & Ratings for Heart Tronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Tronics and related companies with's FREE daily email newsletter.